comparemela.com

Latest Breaking News On - Research development acquired - Page 1 : comparemela.com

AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS

/PRNewswire/ Amgen (NASDAQ: AMGN) today announced financial results for the fourth quarter and full year 2022 versus comparable periods in 2021. "We.

United-states
Puerto-rico
Philadelphia
Pennsylvania
America
American
Jessica-akopyan
Roberta-bradway
Provention-bio
Amgen
National-cancer-institute
American-heart-association-scientific-sessions

AMGEN REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS

/PRNewswire/ Amgen (NASDAQ:AMGN) today announced financial results for the third quarter of 2022. Key results include: Total revenues decreased 1% to $6.7.

Germany
Puerto-rico
Japan
United-states
Philadelphia
Pennsylvania
Japanese
America
American
Jessica-akopyan
Roberta-bradway
Provention-bio

AMGEN REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS

/PRNewswire/ Amgen (NASDAQ:AMGN) today announced financial results for the second quarter of 2022. Key results include: Total revenues increased 1% to $6.6.

Puerto-rico
Japan
United-states
Canada
Turkey
Japanese
American
Jessica-akopyan
Roberta-bradway
Provention-bio
Amgen
European-society-for-medical-oncology-congress

vimarsana © 2020. All Rights Reserved.